Stockscreener 앱 받기
1.16
4.50%
0.05
시간 외 거래:
1.15
-0.01
-0.86%
전일 마감가:
$1.11
열려 있는:
$1.11
하루 거래량:
2.36M
Relative Volume:
0.51
시가총액:
$362.29M
수익:
-
순이익/손실:
$-63.08M
주가수익비율:
-4.2963
EPS:
-0.27
순현금흐름:
$-72.53M
1주 성능:
-2.52%
1개월 성능:
-26.11%
6개월 성능:
+39.76%
1년 성능:
+28.76%
1일 변동 폭
$1.09
$1.1695
1주일 범위
$1.09
$1.271
52주 변동 폭
$0.515
$1.90
오큐젠 Stock (OCGN) Company Profile
명칭
Ocugen Inc
전화
484-328-4701
주소
11 GREAT VALLEY PARKWAY, MALVERN, PA
OCGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.16 | 346.68M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
오큐젠 Stock (OCGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-15 | 개시 | Maxim Group | Buy |
| 2023-03-01 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | 개시 | Mizuho | Buy |
| 2022-06-15 | 재개 | ROTH Capital | Buy |
| 2022-06-02 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-07-26 | 개시 | Noble Capital Markets | Outperform |
| 2021-06-11 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-05-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
모두보기
오큐젠 주식(OCGN)의 최신 뉴스
Will Ocugen Inc. (2H51) stock outperform energy sector in 20252025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Is Ocugen Inc. stock a defensive play in 20252025 Dividend Review & Real-Time Market Trend Scan - newser.com
Why retail investors favor Ocugen Inc. stockWeekly Trend Summary & AI Forecasted Stock Moves - newser.com
How Ocugen Inc. (2H51) stock trades after rate cuts2025 Price Action Summary & Verified Technical Signals - newser.com
Ocugen CEO to Present at NobleCon21-Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference - The Manila Times
Ocugen CEO Dr. Shankar Musunuri to Present at NobleCon21 Conference on Advancements in Gene Therapies for Blindness Diseases - Quiver Quantitative
Ocugen (NASDAQ: OCGN) CEO to Present on Three BLAs in Three Years at NobleCon21 - Stock Titan
How Ocugen Inc. (2H51) stock compares with tech leaders2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Why Ocugen Inc. (2H51) stock could outperform next yearPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Is Ocugen Inc. (2H51) stock resilient in recession scenarios - newser.com
Is Ocugen Inc. showing signs of accumulationSwing Trade & Weekly Top Performers Watchlists - newser.com
How Ocugen Inc. stock reacts to job market data2025 Momentum Check & Low Drawdown Trading Strategies - newser.com
Can Ocugen Inc. stock continue upward trendJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Analyzing net buyer seller activity in Ocugen Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
What hedge fund moves indicate for Ocugen Inc. (2H51) stockRisk Management & Consistent Profit Alerts - newser.com
How Ocugen Inc. stock performs in high volatility marketsWeekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
Can Ocugen Inc. (2H51) stock attract ESG investments2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight - GlobeNewswire Inc.
Is Ocugen Inc. stock resilient to inflationTrade Exit Report & Safe Entry Zone Identification - newser.com
Will Ocugen Inc. stock maintain dividend yieldAnalyst Downgrade & Risk Managed Trade Strategies - newser.com
오큐젠 (OCGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):